spacer
home > news > detailed info
INDUSTRY NEWS AND PRESS RELEASES

Airnov laser-marked desiccant canisters reduced risk of contamination by eliminating print or paper labels

Airnov Healthcare


• Laser marking produces clean, readable, permanent marking
• Enables product and warning labeling without paper, ink or glue
• Reduces risk of contamination of packaged pharmaceuticals and nutraceuticals

August 24, 2020 – Airnov Healthcare Packaging, a global leader in controlled atmosphere packaging, is introducing a new line of laser-marked sorbent and desiccant canisters without direct printing or labeling. Laser marking produces clean, readable product and warning information with reduced risk of contamination of packaged pharmaceuticals and nutraceuticals. It also contributes to a smaller carbon footprint.

Laser marking utilizes the energy of a highly focused laser beam to produce a combined thermal and photochemical effect that results in permanent marking. Airnov has integrated the lasers on its 1-gram canister lines, with the ability to mark on both sides and without sacrificing the high-speed throughput Airnov is known for. Today’s lasers are high-speed and capable of rendering highly detailed, precise imagery and text, and by marking both sides Airnov can include all industry-required symbols and information such as “DO NOT EAT” in multiple languages.

“The pharmaceutical packaging and nutraceutical packaging markets continue to demand a higher level of safety,” says Nicolas Martinez, global product line manager. “We have responded by eliminating extraneous materials like inks, paper and adhesives from the packaging system and offering a much purer replacement.”

The 1-gram drop-in-style canisters are the same size as standard printed and labeled canisters and provide the same protection against chemical or physical drug degradation due to moisture. The canisters are molded in white to facilitate laser marking. The colorant used is the same, GRAS material used in bottles throughout the pharmaceutical industry.

By eliminating the external supply chain required for inks and labels, laser marking reduces the environmental impact by eliminating the associated transportation, packaging, and waste streams. It also reduces time-to-market for non-standard, custom markings.

Dr. Matthias Brommer, Managing Director & CEO, adds, “Laser-marking of canisters represents one of the first innovations launched under our new Airnov brand, and exemplifies our commitment to technology development targeted at satisfying evolving customer demands.”

Ideal for insertion into pharmaceutical and nutraceutical product packaging, canisters can be filled with silica gel for moisture adsorption, activated carbon canisters for odor control, and 2-in-1 canisters deliver moisture and odor control in one unit. Airnov canisters are fully compliant with US FDA and EU regulations for use in pharmaceutical applications and comply with US Pharmacopeia USP <670> standard for pharmaceutical desiccants. A popular and cost-efficient alternative to desiccant packets, which are supplied on reels and must be cut apart before insertion, the rigid canister construction facilitates continuous hopper feeding and high-speed automatic insertion on standard insertion equipment.
phone +33 1 41 76 20 00
email aurelie.emond@airnov-healthcare.com
web https://www.airnov-healthcare.com/
email 6 rue Louise Michel 94 603 Choisy-le-Roi, France
 
Print this page
Send to a friend
   
spacer
News and Press Releases

Europital launches as a science-driven full service CRO

Europital – a globally-focused full service CRO serving small and mid-tier innovators – announces a significant expansion as it launches new capabilities across project management, clinical monitoring, biostatistics, pharmacovigilance, regulatory affairs and data management, in addition to its existing services of Medical Affairs and Medical Writing.
More info >>


White Papers

Crunch Time: The Impact of Serialisation Requirements on Packaging Operations

PCI Pharma Services

The deadlines for including unique product identifiers on prescription drugs is putting a strain on multiple parts of the industry, much of which is ill-prepared to meet the target. Here, we look to the experience of a company that is ahead of the curve for lessons on how to manage and ease the transition to serialisation.
More info >>

Industry Events

Clinical Operations in Oncology Trials West Coast

17-18 November 2020, Hilton San Francisco Airport Bayfront

Clinical Operations in Oncology Trials West Coast will be returning this April for another 2 day event full of thought-provoking presentations, discussions and roundtables. This years' conference highlights include the high-level, interactive immuno-oncology discussion panel where specialists from Shasta Bio Ventures, Abbvie and BeiGene shared their top tips on how to run successful and impactful immuno-oncology studies.
More info >>

 
©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement